Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 25, 2026

Oil Drops on Signs of US Diplomatic Push to End War With Iran

View original at finance.yahoo.com
Oil Drops on Signs of US Diplomatic Push to End War With Iran (Bloomberg) -- Oil fell on signals that a US diplomatic push to try to end the war with Iran may be gathering pace, eclipsing news of more troops being sent to the region and the Strait of Hormuz remaining mainly shut…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • There was now a 'newfound possibility of diplomacy' but US military operations would continue unabated

    60% confidence
  • Iran had offered a 'present' as a show of good faith in talks related to energy flows through the strait

    60% confidence
  • The US sent Iran a 15-point plan to end the conflict

    60% confidence
  • Foreign ships are allowed to pass through Strait of Hormuz as long as they aren't supporting acts of aggression against Iran and follow Iranian regulations

    60% confidence
  • Washington was seeking a one-month ceasefire for talks with Iran

    60% confidence
  • Trump appears to be seeking serious negotiations with Iran, while also keeping his options open

    60% confidence
  • The pullback in oil prices reflects the war-risk premium being cut, but this is unlikely to be seen as an all-clear yet because Iran has publicly denied direct talks while military activity continues

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com
Oil Drops on Signs of US Diplomatic Push to End War With Iran — Source | Via News | ViaNews Market